CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT.  With ICM, they will improve affordability and accessibility of pharmaceuticals on a global scale.

Pharmaceutical

CONTINUUS Pharmaceuticals

Salvatore Mascia

Priya Bharate

Keith Barbato

Fang Yu

Chuntian Hu

Wei Wu

Randall Goyette

Youhua Li

Elizabeth (Liz) Pool, SHRM-SCP

Leonardo Vincenzi

John Costello, CQA

Jason Whipp

Donald Lohman

Dean Hopkins

Bhakti Halkude

Bayan Takizawa

The Scientific and Engineering Team at CONTINUUS Pharmaceuticals focuses on the development and optimization of the Integrated Continuous Manufacturing (ICM) platform. This includes conducting advanced analytical testing, driving computational modeling efforts to enhance process efficiency, and designing mechanical systems for continuous drug production. The team aims to improve the affordability and accessibility of high-quality pharmaceuticals on a global scale.

Scientific and Engineering Team

Directors and Senior Directors

Advisors Team

Scientific and Engineering Team

About

Team members

Other teams at CONTINUUS Pharmaceuticals

Directors and Senior Directors

Advisors Team